When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ETON - Eton Pharmaceuticals down 10% after hours following partner Complete Response Letter
Eton Pharmaceutcials Inc.
Shares of Eton Pharmaceuticals are down 10% in after-hours trading after the company said that Azurity Pharmaceuticals received a Complete Response Letter from the U.S. FDA for its lamotrigine product candidate. Although Eton (NASDAQ:ETON) sold its neurology portfolio to Azurity in 2021, the former is still eligible for milestone payments and sales royalties. Seeking Alpha's Quant Rating views Eton (ETON) as a hold.